Medicine and health ETF (159938) rose 1.99%, with a turnover of 59.2878 million yuan
DATE:  Feb 14 2025

On February 14, GF CSI All-Index Medical and Health ETF (159938) closed up 1.99%, with a turnover of 59.2878 million yuan.

159938Established on December 1, 2014, the full name of the fund is GF CSI All-Index Medical and Health Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as GF CSI All-Index Medical and Health ETF. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the Healthcare ETF (159938) is benchmarked against the CSI All-Index Healthcare Index.

In terms of scale, as of February 13, the latest share of the medical and health ETF (159938) was 7.767 billion shares, and the latest scale was 4.680 billion yuan. Looking back on December 31, 2024, the share of the medical and health ETF (159938) was 7.652 billion shares, with a scale of 4.666 billion yuan. That is, the share of the fund has increased by 1.50% and the scale has increased by 0.29% since the beginning of this year.

In terms of liquidity, as of February 14, the cumulative turnover of the medical and health ETF (159938) in the past 20 trading days was 635 million yuan, with an average daily turnover of 31.7252 million yuan, and since the beginning of this year, the cumulative turnover in 26 trading days has been 884 million yuan, with an average daily turnover of 33.9926 million yuan.

The current fund manager of the Healthcare ETF (159938) is Huo Huaming. Hovamin has managed (or intends to manage) the fund since April 20, 2017, with a return of -8.00% during his tenure.

According to the latest regular report, the heavy stocks of the pharmaceutical and health ETF (159938) include Hengrui Pharmaceutical, Mindray Medical, WuXi AppTec, Pien Tze Huang, Aier Ophthalmology, Yunnan Baiyao, United Imaging Medical, Kelun Pharmaceutical, Xinhecheng, and Shanghai RAAS, with the following proportions.

, , ,
stock symbolstock nameposition ratio, number of shares held (shares).Market value of the position (RMB).
600276 Hengrui Pharmaceutical9.39%, 9,549,900,438,000,300,760
Mindray Medical7.08%, 1,296,330,310,000
603259 WuXi AppTec 6.31% 5,349,400,294 million
600436 Pien Tze Huang 2.97% 645,000,138 million
300015 Aier Ophthalmology 2.83% 9.971 million 132 million
000538 Yunnan Baiyao 2.45% 1.908 million 114 million
688271 United Imaging Medical 2.39%, 881,500, 111 million
002422 Kelun Pharmaceutical, 1.76%, 2,740,582,023,500
002001 Xinhecheng 1.56%, 3,305,6072,624,600
002252 Shanghai RAAS 1.53%, 9,901,671,489,900

Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!

Follow Yicai Global on

star50stocks

Ticker Name

Percentage Change

Inclusion Date